Medipower -M Net Assets
Medipower -M net assets. Based on the latest financial reports, Medipower -M (MDPR) has net assets worth ILA205.71 Million ILA (≈ $551.51K USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA710.68 Million ≈ $1.91 Million USD) and total liabilities (ILA504.97 Million ≈ $1.35 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore MDPR shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA205.71 Million |
| % of Total Assets | 28.95% |
| Annual Growth Rate | 10.81% |
| 5-Year Change | 50.64% |
| 10-Year Change | 220.61% |
| Growth Volatility | 73.83 |
Net Assets of Medipower -M (2006–2025)
Net assets of Medipower -M from 2006 to 2025. This chart illustrates how Medipower -M's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Medipower -M to measure how much of total assets are equity-financed.
Annual Net Assets for Medipower -M (2006–2025)
The table below shows the annual net assets of Medipower -M from 2006 to 2025. For live market cap and overall valuation, see Medipower -M market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA167.55 Million ≈ $449.19K |
+10.57% |
| 2024-12-31 | ILA151.53 Million ≈ $406.26K |
+7.20% |
| 2023-12-31 | ILA141.36 Million ≈ $378.98K |
+6.93% |
| 2022-12-31 | ILA132.20 Million ≈ $354.43K |
+18.86% |
| 2021-12-31 | ILA111.22 Million ≈ $298.18K |
+37.44% |
| 2020-12-31 | ILA80.93 Million ≈ $216.96K |
+3.52% |
| 2019-12-31 | ILA78.17 Million ≈ $209.58K |
+3.68% |
| 2018-12-31 | ILA75.40 Million ≈ $202.14K |
+1.11% |
| 2017-12-31 | ILA74.57 Million ≈ $199.93K |
+42.70% |
| 2016-12-31 | ILA52.26 Million ≈ $140.10K |
+50.01% |
| 2015-12-31 | ILA34.84 Million ≈ $93.40K |
-5.77% |
| 2014-12-31 | ILA36.97 Million ≈ $99.12K |
-2.50% |
| 2013-12-31 | ILA37.92 Million ≈ $101.65K |
-69.84% |
| 2012-12-31 | ILA125.74 Million ≈ $337.09K |
+64.54% |
| 2011-12-31 | ILA76.42 Million ≈ $204.87K |
+310.29% |
| 2010-12-31 | ILA18.62 Million ≈ $49.93K |
-8.10% |
| 2009-12-31 | ILA20.27 Million ≈ $54.33K |
-8.90% |
| 2008-12-31 | ILA22.25 Million ≈ $59.64K |
-36.17% |
| 2007-12-31 | ILA34.85 Million ≈ $93.44K |
+46.28% |
| 2006-12-31 | ILA23.83 Million ≈ $63.88K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medipower -M's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1425.3% over the analyzed period, indicating profitable operations and earnings retention.
Medipower -M Net Assets Breakdown (December 2025)
Medipower -M net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ILA67.71 Million | 46.25% |
| Common Stock | ILA5.11 Million | 3.49% |
| Other Comprehensive Income | ILA4.72 Million | 3.22% |
| Other Components | ILA68.84 Million | 47.03% |
| Total Equity | ILA146.38 Million | 100.00% |
Medipower -M Competitors by Market Cap
The table below lists competitors of Medipower -M ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sinkang Industries Co Ltd
TW:2032
|
$64.97 Million |
|
Super Dragon Technology Co Ltd
TW:9955
|
$64.98 Million |
|
Wspierania Przedsiebiorczosci
WAR:PTW
|
$65.01 Million |
|
ad pepper media International N.V
XETRA:APM
|
$65.05 Million |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
$64.97 Million |
|
Wentel Engineering Holdings Berhad
KLSE:0298
|
$64.96 Million |
|
EN Shoham Business Ltd
TA:SHOM
|
$64.95 Million |
|
Haemato AG
HM:HAEK
|
$64.92 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medipower -M's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 133,267,000 to 146,381,381, a change of 13,114,381 (9.8%).
- Net income of 13,468,101 contributed positively to equity growth.
- Other comprehensive income increased equity by 1,091,980.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA13.47 Million | +9.2% |
| Other Comprehensive Income | ILA1.09 Million | +0.75% |
| Other Changes | ILA-1.45 Million | -0.99% |
| Total Change | ILA- | 9.84% |
Book Value vs Market Value Analysis
This analysis compares Medipower -M's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 165.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 57.83x to 165.55x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | ILA8.19 | ILA473.90 | x |
| 2013-12-31 | ILA2.28 | ILA473.90 | x |
| 2014-12-31 | ILA2.12 | ILA473.90 | x |
| 2015-12-31 | ILA1.90 | ILA473.90 | x |
| 2016-12-31 | ILA1.94 | ILA473.90 | x |
| 2017-12-31 | ILA2.03 | ILA473.90 | x |
| 2018-12-31 | ILA1.82 | ILA473.90 | x |
| 2019-12-31 | ILA1.90 | ILA473.90 | x |
| 2020-12-31 | ILA1.97 | ILA473.90 | x |
| 2021-12-31 | ILA2.28 | ILA473.90 | x |
| 2022-12-31 | ILA2.25 | ILA473.90 | x |
| 2023-12-31 | ILA2.42 | ILA473.90 | x |
| 2024-12-31 | ILA2.61 | ILA473.90 | x |
| 2025-12-31 | ILA2.86 | ILA473.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medipower -M utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.20%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 30.07%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 3.75x
- Recent ROE (9.20%) is above the historical average (5.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 10.24% | 24.92% | 0.09x | 4.62x | ILA265.47K |
| 2013 | 18.74% | 42.63% | 0.11x | 4.01x | ILA2.85 Million |
| 2014 | -2.84% | -6.21% | 0.11x | 4.10x | ILA-3.89 Million |
| 2015 | -4.20% | -9.48% | 0.12x | 3.66x | ILA-3.85 Million |
| 2016 | 4.60% | 16.66% | 0.08x | 3.41x | ILA-2.32 Million |
| 2017 | 7.01% | 29.64% | 0.08x | 3.06x | ILA-1.94 Million |
| 2018 | 6.58% | 23.64% | 0.10x | 2.76x | ILA-2.39 Million |
| 2019 | 5.68% | 21.59% | 0.09x | 3.01x | ILA-3.13 Million |
| 2020 | 3.36% | 10.56% | 0.09x | 3.52x | ILA-5.00 Million |
| 2021 | 9.61% | 29.83% | 0.08x | 4.21x | ILA-377.70K |
| 2022 | 1.18% | 3.58% | 0.09x | 3.68x | ILA-10.08 Million |
| 2023 | 6.48% | 20.72% | 0.09x | 3.37x | ILA-4.36 Million |
| 2024 | 7.64% | 26.00% | 0.09x | 3.12x | ILA-3.14 Million |
| 2025 | 9.20% | 30.07% | 0.08x | 3.75x | ILA-1.17 Million |
Industry Comparison
This section compares Medipower -M's net assets metrics with peer companies in the Real Estate Services industry.
Industry Context
- Industry: Real Estate Services
- Average net assets among peers: $3,228,874,400
- Average return on equity (ROE) among peers: 2.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medipower -M (MDPR) | ILA205.71 Million | 10.24% | 2.45x | $64.97 Million |
| Adgar Investments and Development Ltd (ADGR) | $745.42 Million | 12.38% | 3.38x | $175.86 Million |
| Afi Properties Ltd (AFPR) | $3.04 Billion | 11.83% | 2.20x | $1.83 Billion |
| Alony Hetz Properties and Investments Ltd (ALHE) | $414.29 Million | 17.41% | 4.30x | $1.66 Billion |
| Amot Investments Ltd (AMOT) | $7.60 Billion | 12.26% | 1.31x | $2.37 Billion |
| Argo Properties NV (ARGO) | $330.24 Million | -13.17% | 1.14x | $712.81 Million |
| Ari Real Estate Arena Investment Ltd (ARIN) | $272.87 Million | -30.38% | 4.24x | $471.40 Million |
| Airport City Ltd (ARPT) | $40.40 Million | 20.13% | 17.48x | $1.51 Billion |
| Aspen Group Ltd (ASGR) | $1.62 Billion | 2.18% | 2.31x | $100.16 Million |
| ES Australia Israel Holdings Ltd (AUIS) | $90.47 Million | -12.32% | 0.26x | $12.51 Million |
| Azrieli Group Ltd (AZRG) | $18.13 Billion | 1.04% | 0.94x | $11.12 Billion |
About Medipower -M
Medipower (Overseas) Public Co. Limited, together with its subsidiaries, operates as a commercial real estate company in the United States, Canada, and Bulgaria. It engages in the acquisition, rental, redevelopment, operation, and management of commercial income-generating real estate, primarily retail properties. The company was incorporated in 2001 and is based in Nicosia, Cyprus.